Time has come for immunotherapy in PTCL
Author:
Affiliation:
1. UNIVERSITY LYON 1
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/123/20/3059/1376338/3059.pdf
Reference10 articles.
1. Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.;Horwitz;Blood,2014
2. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.;Gallamini;Blood,2007
3. Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study.;Kim;Cancer Chemother Pharmacol,2007
4. Multicenter phase II study of Mogamulizumab (KW-0761), a defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.;Ogura;J Clin Oncol,2014
5. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.;O’Connor;J Clin Oncol,2011
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice;Theranostics;2017
2. Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review;PLOS ONE;2016-10-06
3. Peripheral T-Cell Lymphoma, Not Otherwise Specified;Diagnostic Pathology: Molecular Oncology;2016
4. Efficient elimination of CD103-expressing cells by anti-CD103 antibody drug conjugates in immunocompetent mice;International Immunopharmacology;2015-01
5. Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications;Immunological Reviews;2014-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3